Health
New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder
People living with schizophrenia or bipolar I disorder (BDI) often face long and complex diagnostic and treatment journeys. Results from a newly completed survey designed to better understand the perspectives of healthcare providers on patients' treatment experiences and outcomes indicated that providers often prioritize approaches that support long-term symptom control, treatment consistency and quality of life considerations. This research was conducted online in the U.S. in September 2024 by
About this update from Alkermes Plc
[{"type":"text","content":"– Survey Respondents Reported That Medication Adherence is a Top Concern for Healthcare Providers When Selecting Treatments and Frequent Medication Switches Can Have Significant Impacts on Patients' Experiences and Quality of Life –","length":236,"tagName":"p","attribs":{}},{"type":"text","content":"– 98% of Respondents Agreed* That Quality of Life for a Patient is Just as Important as Symptom Management When Thinking About Treatment Effect –","length":145,"tagName":"p","attribs":{}},{"type":"text","content":"DUBLIN, March 27, 2025 /PRNewswire/ -- People living with schizophrenia or bipolar I disorder (BDI) often face long and complex diagnostic and treatment journeys. Results from a newly completed survey designed to better understand the perspectives of healthcare providers on patients' treatment experiences and outcomes indicated that providers often prioritize approaches that support long-term symptom control, treatment consistency and quality of life considerations. This research was conducted online in the U.S. in September 2024 by The Harris Poll on behalf of Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), among over 250 healthcare providers who see at least 10 BDI patients per month and at least 2 schizophrenia patients per month. Alkermes is committed to understanding the unique needs of people living with schizophrenia and BDI and driving increased disease awareness and education.","length":945,"tagName":"p"},{"type":"image","alt":"Treating Bipolar 1 Disorder and Schizophrenia: Healthcare Providers Share Perspectives on Treatment Experiences and Outcomes","displaySize":"","headline":null,"caption":"Treating Bipolar 1 Disorder and Schizophrenia: Healthcare Providers Share Perspectives on Treatment Experiences and Outcomes","className":"","disableSlideshowImg":false,"size":{"original":{"width":19,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/15315a79f127ac664b75ba5ad5a75865"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3bt6s65k9W90GSprWf2FBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2O2g9Mzc5O2NmPXdlYnA-/https://media.zenfs.com/en/prnewswire.com/15315a79f127ac664b75ba5ad5a75865","width":19,"height":200}},"href":"https://mma.prnewswire.com/media/2651381/Alkemes_Harris_Poll_BDI_infographic.pdf?p=original","hrefExternal":true,"rel":"nofollow"},{"type":"text","con...